Endoscopic Versus Traditional Craniofacial Resection for Patients with Sinonasal Tumors Involving the Anterior Skull Base.
- Author:
Bong Jik KIM
1
;
Dae Woo KIM
;
Si Whan KIM
;
Doo Hee HAN
;
Dong Young KIM
;
Chae Seo RHEE
;
Chul Hee LEE
Author Information
- Publication Type:Original Article
- Keywords: Nose neoplasms; Skull base; Endoscopic craniofacial resection
- MeSH: Carcinoma, Squamous Cell; Congenital Abnormalities; Cosmetics; Craniotomy; Demography; Esthesioneuroblastoma, Olfactory; Humans; Melanoma; Nose Neoplasms; Skull; Skull Base; Survival Rate
- From:Clinical and Experimental Otorhinolaryngology 2008;1(3):148-153
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVES: With the advent of microdebriders and image guidance systems, endoscope-assisted surgery is now more widely used for the treatment of tumors involving the base of the skull. The aim of this study was to analyze the clinical features of tumors involving the anterior skull base and to evaluate the treatment outcomes according to the surgical approach, which included the traditional craniofacial resection (TCFR) and the endoscopic craniofacial resection with craniotomy (ECFR). METHODS: Forty-six patients who underwent craniofacial resection from 1989 through 2006 at Seoul National University Hospital and Seoul National University Bundang Hospital were included in this study. Demographics, histology, surgical management, surgical outcomes, complications, and morbidity were analyzed. RESULTS: The number of malignant and benign lesions was 40 and 6 cases respectively. The most common diagnosis was olfactory neuroblastoma occurring in 41% of the cases followed by squamous cell carcinoma and malignant melanoma. Thirty-six patients underwent TCFR, while ECFR was performed with or without adjunctive chemotherapy or radiotherapy in 10 patients. The overall five-year survival rate for patients with malignant tumors of the anterior skull base was 47.4%. Out of 19 patients with olfactory neuroblastomas, 10 patients had TCFR and six among them died of their disease. Nine patients underwent ECFR, and none of them died of their disease. The ECFR group had lower morbidity and cosmetic deformity than did the TCFR group. CONCLUSION: The ECFR may be considered as an alternative option for the treatment of selected tumors with anterior skull base invasion. This approach offers the advantages of avoiding facial incisions with comparable treatment results.
